Updated: Jun 3

Tucson, AZ, June 02, 2021—Reglagene announced today that it has been selected to deliver a company presentation at 2021 BIO Digital, the premier biotech event. BIO Digital is scheduled for June 10–11 and 14–18, 2021. CEO Richard Austin, PhD, will present Reglagene’s technology, milestones, and how they plan to fight cancer safely. The presentation will be available to registered attendees at 9:00 am ET June 10.

Attendees at BIO Digital will be able to view Reglagene’s Company Presentation before live meetings in the BIO One-on-One Partnering™ system beginning June 14.

Updated: Apr 5

"That's what we want to do. That is the dream: to irreversibly cure people's cancer," said Richard Austin, the CEO and Co-Founder of Reglagene. Reglagene was featured on KGUN news today!

Updated: Apr 5

Reglagene is proud to announce that our Chief Scientific Officer, Dr. Laurence Hurley, was elected as a fellow of the National Academy of Inventors (NAI). “Election as an NAI fellow is the highest professional distinction accorded solely to academic inventors.”

We are thankful that Dr. Hurley is commercializing his most recent scientific discoveries as the CSO and co-founder of Reglagene. As stated in the article, “Hurley's work has generated the general acceptance of quadruplexes as a new class of validated targets for drug development.” He has a proven track record of success. Dr. Hurley has created four companies, developed two drugs that went through Phase I and II clinical trials, published 278 articles, and is changing the way we fight therapy resistant cancers. Please read the article here!